Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 3:21 PM
Ignite Modification Date:
2025-12-24 @ 3:21 PM
NCT ID:
NCT03980392
Eligibility Criteria:
Inclusion Criteria:
1. Aged 60-79
2. Having at least one among the following dementia risks,
* hypertension
* Diabetes Mellitus
* Dyslipidemia
* Obesity
* Abdominal obesity
* Metabolic syndrome
* Smoking
* educational level ≤ 9 years
* Physical inactivity
* Social inactivity
3. Independent activities of daily living
4. Mini-Mental State Examination score better than1.5 standard deviations below age and education-adjusted normative means
5. Can read and write Korean
6. Having a reliable informant who could provide investigators with the requested information.
7. Provide written informed consent
Exclusion Criteria:
1. Major psychiatric illness such as major depressive disorders
2. Dementia
3. Substantial cognitive decline
4. Other degenerative disease (e.g., Parkinson's disease)
5. Malignancy within 5 years
6. Cardiac stent or revascularization within 1 year
7. Serious or unstable symptomatic cardiovascular disease
8. Other serious or unstable medical disease such as acute or severe asthma, active gastric ulcer, severe liver disease, or severe renal disease
9. Severe loss of vision, hearing, or communicative disability
10. Any conditions preventing cooperation as judged by the study physician
11. Significant laboratory abnormality that may result in cognitive impairment
12. Unable to participate in exercise program safely
13. Coincident participation in any other intervention trial
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
60 Years
Maximum Age:
79 Years
Study:
NCT03980392
Study Brief:
Protocol Section:
NCT03980392